Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

MGRXMGRX
4 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MANGOCEUTICALS INC

Yes. Goldman Sachs holds 11,589 shares of MGRX (Mangoceuticals), worth $4,404, as of its Q2 2026 13F filing. It reduced the position by 168 shares (-1.4%) from Q1 2026. Goldman Sachs has held MGRX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$4,404

Current Shares

11,589

Total Value Change

-$11,662

Total Shares Change

+1,019

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11,589
-1.4%
$4,4040.0%$0.38
0
2026-Q1
New
11,757
-
$4,2340.0%$0.41
22
2025-Q3
Exited
0
-100.0%
$00.0%$2.11
0
2025-Q2
New
10,570
-
$16,0660.0%$1.73
28

Other major holders of MGRX: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used